Accéder au contenu
Merck
Toutes les photos(1)

Documents

53577-U

Supelco

Ascentis® Express 90 Å F5 (2.7 μm) HPLC Columns

L × I.D. 7.5 cm × 3 mm, HPLC Column

Synonyme(s) :

Core-shell (SPP) Fused Core PFP HPLC column

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
41115700
eCl@ss :
32110501
Nomenclature NACRES :
SB.52

product name

Ascentis® Express F5, 2.7 μm HPLC Column, 2.7 μm particle size, L × I.D. 7.5 cm × 3 mm

Matériaux

stainless steel column

Agence

suitable for USP L43

Gamme de produits

Ascentis®

Caractéristiques

endcapped

Fabricant/nom de marque

Ascentis®

Conditionnement

1 ea of

Paramètres

60 °C temp. range
600 bar max. pressure (9000 psi)

Technique(s)

HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable

L × D.I.

7.5 cm × 3 mm

Superficie

135 m2/g

Impuretés

<5 ppm metals

Matrice

Fused-Core particle platform
superficially porous particle

Groupe de la matrice active

PFP (pentafluorophenyl) phase

Taille des particules

2.7 μm

Dimension de pores

90 Å pore size

pH de fonctionnement

2-8

Application(s)

food and beverages

Technique de séparation

reversed phase

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

The pentafluorophenylpropyl stationary phase of Ascentis Express F5 provides a stable reversed phase packing with electron-deficient phenyl rings due to the presence of electronegative fluorines.In addition to forming pi-pi and mildly steric interactions, F5 phases also retain compounds by polar interactions. Ascentis Express F5 can be used for basic, acidic, or neutral compounds with alternate selectivity from C18.

Application


  • Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry.: This study utilizes the Ascentis® Express F5, 2.7 µm HPLC Column to develop a robust method for the determination of lumacaftor in the presence of ivacaftor, identifying five novel degradation products. The high resolution and efficiency of the column were crucial for the detailed analysis and identification process. (Özcan et al., 2023).

  • Stability-indicating LC-MS/MS and LC-DAD methods for robust determination of tasimelteon and high resolution mass spectrometric identification of a novel degradation product.: The Ascentis® Express F5 column was employed to develop stability-indicating methods for tasimelteon, ensuring accurate determination and high-resolution identification of degradation products, highlighting the column′s effectiveness in stability studies and complex sample matrices. (Özcan et al., 2020).

  • Recent trends in ultra-fast HPLC: new generation superficially porous silica columns.: This review discusses advancements in ultra-fast HPLC, focusing on new generation superficially porous silica columns like the Ascentis® Express F5. The article elaborates on the performance improvements and applications in analytical chemistry, emphasizing the column′s role in enhancing speed and resolution. (Ali et al., 2012).

Informations légales

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Nécessaire, mais non fourni

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Choose from one of the most recent versions:

Certificats d'analyse (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Iltaf Shah et al.
The Journal of steroid biochemistry and molecular biology, 180, 118-128 (2018-02-13)
Research shows that immunoassay techniques are not the best choice for the estimation of vitamin D in human blood samples. The main reasons are that some immunoassays are not able to distinguish between 25-OHD3 and 25-OHD2 vitamin D metabolites. Furthermore

Articles

Enhanced selectivity for stereoisomers and closely related compounds with alternate selectivity from C18 phases for basic, acidic, or neutral compounds

Protocoles

Fast and Accurate LC-MS Analysis of Vitamin D Metabolites, Using Ascentis® Express F5 HPLC Columns from Supelco®

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique